Pfizer Inc (PFE)
22 Mar 2018
March 22 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday:
* Ted Baker under pressure after outlook comments (Adds details, closing prices)
LONDON Concerns about trade sent European shares tumbling on Thursday as the United States prepared to announce hefty tariffs on Chinese imports, with banks, basic resources stocks and tech the worst-performing.
* Reckitt gains after pulling out of Pfizer race (Adds details, closing prices)
NEW YORK/LONDON GlaxoSmithKline has pulled ahead in a race to buy Pfizer's consumer healthcare business, which the U.S. drugmaker believes could be worth as much as $20 billion, after its main rival Reckitt Benckiser quit the auction.
* Reckitt shares up more than 5 percent, GSK down 1 percent (Updates with GSK submitting bid)
LONDON Reckitt Benckiser's decision to drop its pursuit of Pfizer's consumer health assets leaves it with a tough job to restore growth to its flat-lining business.
LONDON, March 22 Reckitt Benckiser's decision to drop its pursuit of Pfizer's consumer health assets leaves it with a tough job to restore growth to its flat-lining business.
LONDON, March 22 The UK's top share index declined on Thursday as concerns over potential trade wars weighed on sentiment and traders focused on an upcoming policy decision by the Bank of England.
LONDON, March 22 Concerns around trade sent European shares tumbling to a two-week low on Thursday as the United States prepared to announce hefty tariffs on Chinese imports, with tech stocks and banks the worst-performing.
|Johnson & Johnson (JNJ.N)||$127.38||-3.81|
|Novartis AG (NOVN.S)||CHF76.38||-1.12|
|Merck & Co., Inc. (MRK.N)||$54.12||-0.57|
|Roche Holding Ltd. (ROG.S)||CHF216.40||-2.70|
|Roche Holding Ltd. (RO.S)||CHF218.00||-2.20|
|Abbott Laboratories (ABT.N)||$60.93||-1.49|
|Bayer AG (BAYGn.DE)||€93.03||-1.34|
|Bayer AG (BAYE.F)||--||--|
|Sanofi SA (SASY.PA)||€64.63||--|
|AstraZeneca plc (AZN.L)||4,833.50||-24.00|